Home » Topics » BioWorld Science

BioWorld Science
RSS

Kyoto University develops sequence-selective mitochondrial DNA alkylators for mitochondrial diseases

Sep. 22, 2021

Mouse models, MOS models, organoids can make personalized predictions

Sep. 21, 2021

Trigone Pharma collaborates with 4C Biomed on intravesical immunotherapy for bladder cancer

Sep. 21, 2021

Virpax acquires rights to Nanomerics' technology to deliver intranasal cannabidiol product

Sep. 21, 2021

KLF5 inhibitor AM-80 ameliorates muscular atrophy in mice

Sep. 21, 2021

Blade reports preclinical drug-drug interaction data on cudetaxestat for IPF

Sep. 21, 2021

ChAdOx1/MVA MAGE vaccine shows synergy with anti-PD-1 cancer therapy

Sep. 21, 2021

Mindset reports preclinical data on next-generation psychedelic medicine MSP-4018

Sep. 21, 2021

Linagliptin ameliorates neurodegeneration in rat model of AD

Sep. 21, 2021

Celularity and Oncternal collaborate to study placental-derived cellular therapies targeting ROR1

Sep. 21, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...